LETTER
An Acetone-derived Chiral Stabilised Azomethine Ylid
requires 391.1657, 391(55), 104(100).
1839
(5) (a) Anslow, A. S.; Harwood, L. M.; Phillips, H.; Watkin, D.
Tetrahedron: Asymmetry 1991, 2, 169. (b) Anslow, A. S.;
Harwood, L. M.; Phillips, H.; Watkin, D. Tetrahedron:
Asymmetry 1991, 2, 997. (c) Anslow, A. S.; Harwood, L.
M.; Phillips, H.; Watkin, D. J.; Wong, L. F. Tetrahedron:
Asymmetry 1991, 2, 1343. (d) Harwood, L. M.; Lilley, I. A.
Tetrahedron Lett. 1993, 537. (e) Harwood, L. M.; Kitchen,
L. C. Tetrahedron Lett. 1993, 6603. (f) Anslow, A. S.; Cox,
G. G.; Harwood, L. M. Chemistry of Heterocyclic
N-Phenyl (2S,6S,7S,8R)-9,9-dimethyl-2-phenyl-1-aza-4-
oxa[4.3.01,6]bicyclononan-5-one-7,8-dicarboximide (5a):
Colourless crystals (30%), mp 188–189 °C, [ ]D25 –50.5 (c
0.45, CHCl3); (Found C, 70.68; H, 5.65; N, 7.08.
C23H22N2O4 requires C, 70.75; H, 5.68; N, 7.17%.);
max
(KBr disc): 1754, 1712 cm–1; 1H NMR (250 MHz, CDCl3)
= 7.57–7.30 (10 H, m), 4.53 (1 H, s), 4.47 (1 H, m), 4.30 (1
H, m), 4.24 (1 H, d, J’= 8.4 Hz), 4.06 (1 H, t, J = 11.5 Hz),
3.23 (1 H, d, J = 8.4 Hz), 1.24 (3 H, s), 1.01 (3 H, s); NOE
Compounds 1995, 10, 1393. (g) Harwood, L. M.; Lilley, I.
A. Tetrahedron: Asymmetry 1995, 6, 1557. (h) Anslow, A.
S.; Harwood, L. M.; Lilley, I. A. Tetrahedron: Asymmetry
1995, 6, 2465. (i) Harwood, L. M.; Lilley, I. A. Synlett 1996,
1010.
H6
H3 10.0%; 13C NMR (62.5 MHz, CDCl3):
=
176.4, 174.3, 171.8, 139.0, 131.4, 129.4, 128.9, 128.2,
126.4, 70.9, 66.2, 60.9, 54.6, 54.2, 44.1, 26.7, 23.6; MS
(C.I.): m/z 391.1643 [MH+] C23H22N2O4 requires 391.1657,
391 (56), 104 (100).
(6) Preparation of (5S)-N-(methoxy-1-methylethyl)-5-
phenylmorpholin-2-one (2):
Methyl (2S,6S,8S)-9,9-dimethyl-2-phenyl-1-aza-4-
oxa[4.3,01,6]bicyclononan-5-one-8-carboxylate (4e):
Colourless crystals (14%), mp 100–106 °C, [ ]D25 +6.3 (c
0.20, CHCl3); max (KBr disc): 1750, 1741 cm–1; 1H NMR
(250 MHz, CDCl3): = 7.47–7.29 (5 H, m), 4.28–4.10 (4 H,
m), 3.70 (3 H, s), 2.99–2.80 (2 H, m), 2.43–2.34 (1 H, m),
0.90 (6 H, s); 13C NMR (63 MHz, CDCl3): = 175.0, 172.3,
142.0, 129.0, 128.4, 127.5, 71.2, 64.2, 56.6, 56.2, 54.2 52.2,
28.3, 26.4, 16.3; MS (C.I.): m/z 304.1554 [MH+] C17H22N4
requires 304.1548.
Dimethoxypropane (0.16 mL, 1.36 mmol, 2 equiv) was
added via syringe to a suspension of (5S)-5-phenyl-
morpholin-2-one (120 mg, 0.68 mmol, 1 equiv) and
magnesium bromide etherate (174 mg, 0.68 mmol, 1 equiv)
in 10 mL THF. The reaction mixture was heated to reflux
under nitrogen for 2.5 h. The solution was then allowed to
cool down to r.t. and was filtered through a short pad of
silica, washing with ethyl acetate. The solvent was removed
in vacuo and flash chromatography on silica using petroleum
ether–ethyl acetate 1:1 furnished the title compound as a
yellow oil (yields variable). max(film): 1741 cm–1; 1H NMR
(400 MHz, CDCl3): = 7.43–7.26 (5 H, m), 4.30 (1 H, t, J =
7.9 Hz), 4.17 (1 H, t, J = 7.9 Hz), 3.67 (1 H, t, J = 7.9 Hz),
3.51 (3 H, s), 3.37 (1 H, d, J = 16.5 Hz), 3.28 (1 H, d, J = 16.5
Hz), 1.46 (3 H, s), 1.30 (3 H, s); 13C NMR (100 MHz,
CDCl3): = 172.4, 128.9, 128.7, 128.2, 128.1, 128.0, 127.6,
95.5, 72.2, 65.7, 51.7, 48.4, 27.9, 22.4; MS (C.I.): m/z
250.1441 [MH+] C14H20NO3 requires 250.1443.
(10) Crystallographic data for the structures reported in this paper
have been deposited with the Cambridge Crystallographic
Data Centre; reference numbers CCDC 169323 (4a), 169324
(4c), 169325 (4d), 169326 (4e), 169327 (5a), 169328 (5b).
Copies of the data can be obtained on application to CCDC,
12 Union Road, Cambridge CB2 1EZ, UK (fax:
+44(1223)336033; e-mail: deposit@ccdc.cam.ac.uk).
(11) Harwood, L. M.; Manage, A. C.; Robin, S.; Hopes, S. F. G.;
Watkin, D. J.; Williams, C. E. Synlett 1993, 777.
(7) (a) Williams, R. M.; Zhai, W.; Aldous, D. J.; Aldous, S. C.
J. Org. Chem. 1992, 57, 6527. (b) Sebaha, R.; Williams, R.
M. J. Am. Chem. Soc. 2000, 122, 5666.
(8) Alker, D.; Harwood, L. M.; Williams, C. E. Tetrahedron
1997, 53, 12671.
(12) Cordes, E. H. Prog. Phys. Org. Chem. 1967, 4, 1.
(13) O' Neil, I. Synlett 1991, 661.
(14) General Method for the Preparation of Prolines 6a–e,
7a–c: The cycloadduct (1 equiv) was dissolved in aq
methanol (20:1 MeOH:H2O, 20 mL mmol–1) in a Fisher
Porter bottle. TFA (9 L, 0.12 mmol, 1 equiv) and
Pearlman’s Catalyst (palladium hydroxide, 1 equiv by mass)
were added to the stirred suspension, which was then
degassed and subjected to hydrogen at 5 atm for two days.
The solution was then passed through a pad of Celite® to
remove the catalyst and the solvent removed in vacuo.
Trituration of the crude mixture with diethyl ether allowed in
some cases the precipitation of the amino acid as a colourless
powder, which was then filtered and dried in vacuo. If the
amino acid could not be obtained by trituration, it was
purified by reverse phase dry flash column chromato-
graphy,13 eluting with methanol–water 1:1.
(9) General Method for Preparation of Cycloadducts 4a–e
and 5a–c: Dimethoxypropane (2 equiv) was added via
syringe to a suspension of (5S)-5-phenylmorpholin-2-one
(1 equiv), dipolarophile (2 equiv) and magnesium bromide
etherate (1 equiv) in THF (15 mL mmol–1 of morpholinone).
The reaction mixture was heated to reflux under nitrogen for
2.5 h. The solution was then allowed to cool down to r.t. and
was filtered through a short pad of silica, washing with ethyl
acetate. Removal of the solvent in vacuo yielded the crude
mixture along with excess dipolarophile. Flash chromato-
graphy using gradient elution, typically petroleum ether–
ethyl acetate 3:1 to petroleum ether–ethyl acetate 1:1,
furnished the pure compounds.
Selected Spectroscopic Data of (2S,3R,4S)-5,5-Dimethyl-
3,4-(N-phenyldicarboximido)pyrrolidine-2-carboxylic
Acid (6a): Colourless powder (72%), mp 220–228 °C, [ ]D
Selected Spectroscopic Data of N-Phenyl-(2S,6S,7R,8S)-
9,9-dimethyl-2-phenyl-1-aza-4-oxa[4.3.01,6]bicyclo-
nonan-5-one-7,8-dicarboximide (4a): Colourless crystals
(43%), mp 210–216 °C, [ ]D25 +16.2 (c 0.55, CHCl3);
(Found C, 70.40; H, 5.62; N, 7.00. C23H22N2O4 requires C,
70.75; H, 5.68; N, 7.17%.); max (KBr disc): 1751, 1712
cm–1; 1H NMR (250 MHz, CDCl3): = 7.53–7.29 (10 H, m),
4.59 (1 H, d, J = 8.4 Hz,), 4.51 (1 H, dd, J = 5.7, J’ = 11.3
Hz), 4.33 (1 H, dd, J = 5.7, J’= 10.1 Hz), 4.16 (1 H, dd, J =
10.1, J’= 11.5 Hz), 3.90 (1 H dd, J = 8.4, J’= 10.0 Hz), 3.34
(1 H, d, J = 10.0 Hz), 1.23 (3 H, s), 1.12 (3 H, s); NOE H6
25
44.4 (c 0.45, MeOH); max (KBr disc): 3400, 1716, 1710,
1704 cm–1; 1H NMR (250 MHz, CD3OD): = 7.50–7.29 (5
H, m), 4.80 (1 H, d, J = 8.6 Hz), 4.17 (1 H, t, J = 8.6 Hz),
3.50 (1 H, d, J = 8.6 Hz), 1.65 (3 H, s,), 1.59 (3 H, s); 13
C
NMR (62.5 MHz, MeOD): = 175.0, 134.1, 130.5, 130.3,
128.6, 66.5, 61.6, 54.3, 48.1, 28.1, 23.0; MS (C.I.): m/z
289.1184 [MH+] C15H16N2O4 requires 289.1188.
(2S,3S,4R)-5,5-Dimethyl-3,4-(N-phenyldicarbox-
imido)pyrrolidine-2-carboxylic acid (7a): Colourless
powder (81%), mp 168–170 °C, [ ]D25 +51.3 (c 0.30,
MeOH); max (KBr disc): 3400, 1721, 1716, 1711 cm–1; 1H
NMR (250 MHz, CD3OD): = 7.57–7.31 (5 H, m), 4.70
(1 H, d, J = 4.2 Hz), 4.31 (1 H, dd, J = 4.2, J’ = 9.3 Hz), 3.59
H3 8.5%, H7
H6 8.0%; 13C NMR (62.5 MHz,
CDCl3): = 175.0, 173.5, 170.3, 139.3, 131.8, 129.2, 129.0,
128.7, 128.3, 126.6, 71.8, 65.0, 58.6, 55.7, 54.8, 44.4, 30.4,
18.3 (CH3); MS (C.I.): m/z 391.1643 [MH+] C23H22N2O4
Synlett 2001, No. X, 1836–1840 ISSN 0936-5214 © Thieme Stuttgart · New York